ImmunityBio (IBRX) Prepaid Assets (2014 - 2026)

ImmunityBio (IBRX) has 13 years of Prepaid Assets data on file, last reported at $28.3 million in Q1 2026.

• On a quarterly basis, Prepaid Assets rose 1100.72% year-over-year to $28.3 million in Q1 2026; TTM through Mar 2026 was $28.3 million, a 1100.72% increase from a year earlier, with the FY2025 full-year figure at $2.1 million, down 91.05% from the prior year.
• Prepaid Assets for Q1 2026 stood at $28.3 million, up from $2.1 million in the prior quarter.
• Over the last five years, Prepaid Assets for IBRX reached as high as $32.9 million in Q3 2025 and fell as low as $1.4 million in Q3 2024.
• Historically, Prepaid Assets has averaged $14.5 million across 5 years, with a median of $16.1 million in 2022.
• Across the five-year window, Prepaid Assets surged 2732.34% in 2022 and sank 94.05% in 2024, its largest moves.
• Year by year, Prepaid Assets stood at $2.0 million in 2022, then jumped by 1193.73% to $25.6 million in 2023, then fell by 6.84% to $23.9 million in 2024, then slumped by 91.05% to $2.1 million in 2025, then surged by 1223.33% to $28.3 million in 2026.
• Per Business Quant data, the three most recent Prepaid Assets figures were $28.3 million in Q1 2026, $2.1 million in Q4 2025, and $32.9 million in Q3 2025.